Merit Medical Systems, Inc. (NASDAQ:MMSI) Stock Has Consensus Target Price of $100.00

Shares of Merit Medical Systems, Inc. (NASDAQ:MMSI) have earned a consensus rating of “Moderate Buy” from the twelve analysts that are covering the company, MarketBeat.com reports. Three investment analysts have rated the stock with a hold recommendation, eight have issued a buy recommendation and one has given a strong buy recommendation to the company. The average 1-year target price among analysts that have issued ratings on the stock in the last year is $100.00.

Several brokerages have commented on MMSI. Canaccord Genuity Group raised their target price on shares of Merit Medical Systems from $85.00 to $94.00 and gave the stock a “buy” rating in a report on Friday, July 31st. Piper Sandler upped their price target on shares of Merit Medical Systems from $96.00 to $106.00 and gave the company an “overweight” rating in a report on Friday, July 31st. JPMorgan Chase & Co. increased their price objective on shares of Merit Medical Systems from $77.00 to $95.00 and gave the stock an “overweight” rating in a research report on Friday, July 31st. Weiss Ratings raised shares of Merit Medical Systems from a “hold (c-)” rating to a “hold (c)” rating in a research report on Tuesday, August 18th. Finally, Robert W. Baird set a $98.00 price objective on shares of Merit Medical Systems in a report on Friday, July 31st.

Hedge Funds Weigh In On Merit Medical Systems

Large investors have recently added to or reduced their stakes in the company. QRG Capital Management Inc. raised its stake in shares of Merit Medical Systems by 10.9% in the 2nd quarter. QRG Capital Management Inc. now owns 9,305 shares of the medical instruments supplier’s stock valued at $645,000 after purchasing an additional 917 shares during the period. Talon Private Wealth LLC boosted its position in shares of Merit Medical Systems by 36.4% during the second quarter. Talon Private Wealth LLC now owns 11,727 shares of the medical instruments supplier’s stock worth $813,000 after buying an additional 3,130 shares during the period. Sequoia Financial Advisors LLC acquired a new position in shares of Merit Medical Systems during the second quarter worth about $282,000. Van Hulzen Asset Management LLC boosted its position in shares of Merit Medical Systems by 25.0% during the second quarter. Van Hulzen Asset Management LLC now owns 28,877 shares of the medical instruments supplier’s stock worth $2,002,000 after buying an additional 5,778 shares during the period. Finally, Integrated Wealth Concepts LLC bought a new position in shares of Merit Medical Systems during the second quarter worth about $199,000. Institutional investors own 99.66% of the company’s stock.

Merit Medical Systems Stock Up 1.0%

Shares of Merit Medical Systems stock opened at $87.87 on Friday. The company has a market capitalization of $5.25 billion, a P/E ratio of 36.31, a price-to-earnings-growth ratio of 2.17 and a beta of 0.49. The company has a debt-to-equity ratio of 0.44, a current ratio of 4.20 and a quick ratio of 2.79. The business has a 50-day moving average of $86.86 and a two-hundred day moving average of $74.33. Merit Medical Systems has a 1 year low of $59.74 and a 1 year high of $94.75.

Merit Medical Systems (NASDAQ:MMSI) last released its quarterly earnings data on Thursday, July 30th. The medical instruments supplier reported $1.19 earnings per share for the quarter, beating the consensus estimate of $0.96 by $0.23. Merit Medical Systems had a return on equity of 13.75% and a net margin of 9.22%.The business had revenue of $418.84 million for the quarter, compared to analysts’ expectations of $405.25 million. During the same quarter in the previous year, the business posted $1.01 EPS. Merit Medical Systems’s revenue for the quarter was up 9.5% on a year-over-year basis. Merit Medical Systems has set its FY 2026 guidance at 4.250-4.350 EPS. As a group, equities analysts predict that Merit Medical Systems will post 3.84 EPS for the current year.

About Merit Medical Systems

Merit Medical Systems, Inc is a medical device company that develops, manufactures and markets disposable products used in interventional, diagnostic and therapeutic procedures. Its portfolio is designed primarily for use by physicians in hospitals, outpatient facilities and other healthcare settings.

The company’s products support a range of specialties, including cardiovascular intervention, peripheral intervention, oncology, spine and pain management, general surgery, and critical care.